The role of LOXL4 in tumor progression in laryngeal SCC has yet to be determined clearly but our findings in light of the literature suggest that LOXL4 is an enzyme overexpressed by an advancing SCC that is lost with worsening differentiation and confers a survival advantage by hitherto undefined tumor suppressive properties. The gene discussed is LOXL4; the disease is neoplasm.